fda glp-1 news november 2025 Lilly is now pharma's top revenue company. It just got approval for an oral GLP-1, but Wall Street isn't celebrating glp-1 shortages news november 2025

As Medicare broadens reimbursement opportunities for GLP-1 medications under qualifying conditions, pharmaceutical companies, healthcare advertisers, providers, and payers are adapting their strategies to meet growing demand

This hormone responds to food intake and plays a critical role in regulating blood sugar levels by stimulating insulin secretion and reducing the production of glucagon, another hormone that raises blood sugar

facility to the highest standards, from formulation to final packaging

Tirzepatide is a dual GIP/GLP-1 receptor agonist, meaning it activates two hormonal pathways involved in appetite regulation and blood sugar control